- Home
- BLDE vs RZLT Comparison
BLDE vs RZLT Comparison
Compare BLDE & RZLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLDE
- RZLT
- Stock Information
- Founded
- BLDE 2014
- RZLT 2010
- Country
- BLDE United States
- RZLT United States
- Employees
- BLDE N/A
- RZLT N/A
- Industry
- BLDE Aerospace
- RZLT Biotechnology: Pharmaceutical Preparations
- Sector
- BLDE Consumer Discretionary
- RZLT Health Care
- Exchange
- BLDE Nasdaq
- RZLT Nasdaq
- Market Cap
- BLDE 276.7M
- RZLT 292.0M
- IPO Year
- BLDE N/A
- RZLT N/A
- Fundamental
- Price
- BLDE $4.11
- RZLT $4.87
- Analyst Decision
- BLDE Buy
- RZLT Strong Buy
- Analyst Count
- BLDE 1
- RZLT 8
- Target Price
- BLDE $6.00
- RZLT $11.63
- AVG Volume (30 Days)
- BLDE 1.0M
- RZLT 349.3K
- Earning Date
- BLDE 03-11-2025
- RZLT 02-11-2025
- Dividend Yield
- BLDE N/A
- RZLT N/A
- EPS Growth
- BLDE N/A
- RZLT N/A
- EPS
- BLDE N/A
- RZLT N/A
- Revenue
- BLDE $241,814,000.00
- RZLT N/A
- Revenue This Year
- BLDE $11.34
- RZLT N/A
- Revenue Next Year
- BLDE $5.73
- RZLT N/A
- P/E Ratio
- BLDE N/A
- RZLT N/A
- Revenue Growth
- BLDE 12.04
- RZLT N/A
- 52 Week Low
- BLDE $2.45
- RZLT $0.92
- 52 Week High
- BLDE $5.17
- RZLT $6.19
- Technical
- Relative Strength Index (RSI)
- BLDE 49.59
- RZLT 49.47
- Support Level
- BLDE $3.43
- RZLT $4.47
- Resistance Level
- BLDE $5.14
- RZLT $4.98
- Average True Range (ATR)
- BLDE 0.35
- RZLT 0.33
- MACD
- BLDE -0.05
- RZLT -0.01
- Stochastic Oscillator
- BLDE 39.77
- RZLT 38.10
About BLDE Blade Air Mobility Inc.
Blade Air Mobility Inc is a technology-powered air mobility platform that provides air transportation and logistics for hospitals and is a transporter of human organs for transplant, and for passengers, with helicopter and fixed-wing services predominantly in the Northeast United States, Southern Europe and Western Canada. The company's operating segments are; Passenger, and Medical. Majority of the revenue for the company is generated from its Medical segment which predominantly consists of transportation of human organs for transplant and the medical teams supporting these services. It also offers additional services including donor logistics coordination and support in evaluating potential donor organs. A substantial portion of the company's revenue is generated from the United States.
About RZLT Rezolute Inc. (NV)
Rezolute Inc is a biopharmaceutical company. The company develops novel, sustained-release injectable therapies. It applies proprietary formulation and manufacturing capabilities to known, well-characterized molecules to create differentiated, patent-protected therapies that have the potential to significantly improve existing standards of care. Its pipeline products include RZ358 and RZ402.